Clinical Trial Update: Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in newly diagnosed multiple myeloma assessing sequential VAD and VTD induction followed by high-dose therapy with autologous stem cell tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Adriamycin (doxorubicin)
• Decadron (Dexamethasone)
• Oncovin (vincristine)
• Thalomid (thalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: Korean Multiple Myeloma Working Party | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN